Why the study?
Is plasma S100A12 protein level associated with the prevalence of cardiovascular disease in hemodialysis patients?
Is plasma S100A12 protein level associated with the prevalence of cardiovascular disease in hemodialysis patients?
Plasma S100A12 may serve as a biomarker associated with cardiovascular disease in patients undergoing hemodialysis.
Answers are grounded in this paper and cite their sources.
Does not support routine S100A12 testing in hemodialysis; hypothesis-generating for biomarker research in CVD.
These results suggest that the plasma S100A12 protein level is strongly associated with the prevalence of cardiovascular disease in hemodialysis patients.
No takes yet. Share an insight, caveat, or question.
Shiotsu et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: